Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
21
2024
A Psychedelic Use Case for AI Nelson Mullins
Mar
11
2020
A Recipe for Disaster: The Impact of COVID-19 on Food Safety and the Food Industry Bilzin Sumberg
Nov
23
2020
A Record-Breaking Year in Digital Health Investments: Key Takeaways | HTLH GoLive Webinar
Nov
4
2021
A Reminder of Doctrine of Equivalents in Biotechnology: Jennewein Biotechnologie GmbH v. International Trade Commission Proskauer Rose LLP
Nov
20
2014
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 Michael Best & Friedrich LLP
Oct
27
2014
A Review of the Status of Biosimilars in the U.S. Michael Best & Friedrich LLP
Oct
31
2022
A Safety Warning May Be Required for Black Licorice Used in Compliance with a GRAS Regulation Keller and Heckman LLP
Sep
28
2023
A Second Chance to Win Your Government Healthcare Contract Sheppard, Mullin, Richter & Hampton LLP
Mar
1
2015
A Second Look At The Innovation Act Obviousness Type Double Patenting Statute Foley & Lardner LLP
Jul
6
2013
A Short-Lived Victory for Generic Drug Manufacturers? Sheppard, Mullin, Richter & Hampton LLP
Jul
27
2020
A Shot Across the Bow of the Pharmaceutical Industry: President Trump Issues a Quartet of Executive Orders on Drug Pricing that Might Eventually (OR NEVER?) Take Effect Sheppard, Mullin, Richter & Hampton LLP
Jan
10
2020
A Simple Guide to Zantac Cancer Lawsuits and Settlements Stark & Stark
Apr
25
2019
A Special “Treatment” for Patent Eligibility McDermott Will & Emery
Feb
8
2011
A Sputnik Moment for Renewable Energy or Another Failed Launch? Michael Best & Friedrich LLP
Dec
2
2015
A Substantially Pure Isomer Is Obvious When the Completely Pure Isomer Is Known In The Art: Spectrum Pharms., Inc. v. Sandoz Inc. McDermott Will & Emery
Nov
14
2014
A Taste of Things to Come? Whole Foods Feels Sting of “Non-GMO” Litigation Mintz
Jul
19
2022
A Third Surge in Innovation and Patents on Hydrogen Fuel Cell Vehicles Foley & Lardner LLP
Mar
22
2016
A Time to Train: FDA Compliance Keller and Heckman LLP
Jun
22
2022
A Truly Piscatory Exemption Allen Matkins Leck Gamble Mallory & Natsis LLP
Jul
24
2013
A Two-fer: North Carolina Lawsuits Over Damage to Coastal Wetlands and Damage by Local Government Prayer Womble Bond Dickinson (US) LLP
Apr
24
2023
A UK Perspective on Dealing with Alcohol Dependence in the Workplace Vedder Price
Oct
5
2014
A Warehouse Full of Unapproved Genetically-Modified Seeds; Now What?, Syngenta Seeds, Inc. v. Bunge North America, Inc. McDermott Will & Emery
Jun
16
2020
A Warning to One, A Warning to All? ArentFox Schiff LLP
Aug
7
2023
A Watched Pot Never Boils: SAFE Banking on the Backburner Again Bradley Arant Boult Cummings LLP
Jan
3
2023
A Way Too Early Prediction: Alabama Cannabis 2.0 Bradley Arant Boult Cummings LLP
Sep
17
2019
A Win for Hemp in Court, and What it (Might) Mean for North Carolina Ward and Smith, P.A.
Dec
20
2023
A Win for Skinny Labels: Insights for Enforcing Use Patents Squire Patton Boggs (US) LLP
Apr
15
2024
A Win for the SEC on Shadow Trading. Now What? ArentFox Schiff LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins